Literature DB >> 30930009

Transfusion-Transmitted Infections Reported to the National Healthcare Safety Network Hemovigilance Module.

Kathryn A Haass1, Mathew R P Sapiano2, Alexandra Savinkina3, Matthew J Kuehnert4, Sridhar V Basavaraju4.   

Abstract

Transfusion-transmitted infections (TTIs) can be severe and result in death. Transfusion-transmitted viral pathogen transmission has been substantially reduced, whereas sepsis due to bacterial contamination of platelets and transfusion-transmitted babesiosis may occur more frequently. Quantifying the burden of TTI is important to develop targeted interventions. From January 1, 2010, to December 31, 2016, health care facilities participating in the National Healthcare Safety Network Hemovigilance Module monitored transfusion recipients for evidence of TTI and recorded the total number of units transfused. Facilities use standard criteria to report TTIs. Incidence rates of TTIs, including for bacterial contamination of platelets and transfusion-transmitted babesiosis, are presented. One hundred ninety-five facilities reported 111 TTIs and 7.9 million transfused components to the National Healthcare Safety Network Hemovigilance Module. Of these 111 reports, 54 met inclusion criteria. The most frequently reported pathogens were Babesia spp in RBCs (16/23, 70%) and Staphylococcus aureus in platelets (12/30, 40%). There were 1.95 (26 apheresis, 4 whole blood derived) TTIs per 100 000 transfused platelet units and 0.53 TTI per 100 000 transfused RBC components, compared to 0.68 TTI per 100 000 all transfused components. Bacterial contamination of platelets and transfusion-transmitted babesiosis were the most frequently reported TTIs. Interventions that reduce the burden of bacterial contamination of platelets, particularly collected by apheresis, and Babesia transmission through RBC transfusion would reduce transfusion recipient morbidity and mortality. These analyses demonstrate the value and importance of facility participation in national recipient hemovigilance using standard reporting criteria. Published by Elsevier Inc.

Entities:  

Keywords:  Babesia spp.; Bacterial contamination; Hemovigilance; Transfusion-transmitted infections

Mesh:

Year:  2019        PMID: 30930009      PMCID: PMC6520165          DOI: 10.1016/j.tmrv.2019.01.001

Source DB:  PubMed          Journal:  Transfus Med Rev        ISSN: 0887-7963


  10 in total

Review 1.  Blood Transfusion Reactions-A Comprehensive Review of the Literature including a Swiss Perspective.

Authors:  Theresa Ackfeld; Thomas Schmutz; Youcef Guechi; Christophe Le Terrier
Journal:  J Clin Med       Date:  2022-05-19       Impact factor: 4.964

2.  Acquired platelet storage container leaks and contamination with environmental bacteria: A preventable cause of bacterial sepsis.

Authors:  Richard R Gammon; Rita A Reik; Marc Stern; Ralph R Vassallo; Dan A Waxman; Pampee P Young; Richard J Benjamin
Journal:  Transfusion       Date:  2021-12-20       Impact factor: 3.337

3.  Transfusion-associated adverse events and implementation of blood safety measures - findings from the 2017 National Blood Collection and Utilization Survey.

Authors:  Alexandra A Savinkina; Kathryn A Haass; Mathew R P Sapiano; Richard A Henry; James J Berger; Sridhar V Basavaraju; Jefferson M Jones
Journal:  Transfusion       Date:  2020-03       Impact factor: 3.337

4.  Overwhelming Asplenic Sepsis due to Babesiosis

Authors:  Chakra P. Chaulagain
Journal:  Turk J Haematol       Date:  2019-06-25       Impact factor: 1.831

5.  Non-evidence-based platelet transfusions for protocol eligibility.

Authors:  Sarah Vossoughi; Joseph Schwartz
Journal:  Cytotherapy       Date:  2020-05-03       Impact factor: 5.414

6.  Blood utilisation and transfusion reactions in adult patients transfused with conventional or pathogen-reduced platelets.

Authors:  Burak Bahar; Wade L Schulz; Amit Gokhale; Bryan R Spencer; Eric A Gehrie; Edward L Snyder
Journal:  Br J Haematol       Date:  2019-09-30       Impact factor: 6.998

7.  Platelet transfusion for neonates with thrombocytopaenia: protocol for a systematic review.

Authors:  Dengjun Liu; Jinlin Wu; Tao Xiong; Yan Yue; Jun Tang
Journal:  BMJ Open       Date:  2020-10-16       Impact factor: 2.692

8.  Expanded validation of the effect and quality of a pathogen inactivation system based on riboflavin photochemistry on platelet bacterial contamination.

Authors:  Bin Fan; Meng Yi; Guang Yang; Lu Yang; Wei Shang; Yi Liu; Xiaolong Zhong; Liguo Zhu; Deqing Wang
Journal:  Ann Transl Med       Date:  2021-12

Review 9.  Platelet Transfusion-Insights from Current Practice to Future Development.

Authors:  Annina Capraru; Katarzyna Aleksandra Jalowiec; Cesare Medri; Michael Daskalakis; Sacha Sergio Zeerleder; Behrouz Mansouri Taleghani
Journal:  J Clin Med       Date:  2021-05-06       Impact factor: 4.241

Review 10.  A consideration of convalescent plasma and plasma derivatives in the care of Severely-ill patients with COVID-19.

Authors:  Thomas Lung; Michel D Kazatchkine; Lorenz Risch; Martin Risch; Urs E Nydegger
Journal:  Transfus Apher Sci       Date:  2020-09-05       Impact factor: 1.764

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.